Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 13:21:04 UTC |
---|
Update Date | 2021-09-26 23:07:58 UTC |
---|
HMDB ID | HMDB0254164 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Lorlatinib |
---|
Description | Lorlatinib belongs to the class of organic compounds known as macrolactams. These are cyclic amides of amino carboxylic acids, having a 1-azacycloalkan-2-one structure, or analogues having unsaturation or heteroatoms replacing one or more carbon atoms of the ring. They are nitrogen analogues (the a nitrogen atom replacing the o atom of the cyclic carboxylic acid group ) of the naturally occurring macrolides. Based on a literature review a significant number of articles have been published on Lorlatinib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Lorlatinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Lorlatinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=C1C=C(F)C=C2 InChI=1S/C21H19FN6O2/c1-11-15-7-13(22)4-5-14(15)21(29)27(2)10-16-19(17(8-23)28(3)26-16)12-6-18(30-11)20(24)25-9-12/h4-7,9,11H,10H2,1-3H3,(H2,24,25) |
---|
Synonyms | Not Available |
---|
Chemical Formula | C21H19FN6O2 |
---|
Average Molecular Weight | 406.421 |
---|
Monoisotopic Molecular Weight | 406.155352039 |
---|
IUPAC Name | 19-amino-13-fluoro-4,8,16-trimethyl-9-oxo-17-oxa-4,5,8,20-tetraazatetracyclo[16.3.1.0^{2,6}.0^{10,15}]docosa-1(22),2,5,10(15),11,13,18,20-octaene-3-carbonitrile |
---|
Traditional Name | 19-amino-13-fluoro-4,8,16-trimethyl-9-oxo-17-oxa-4,5,8,20-tetraazatetracyclo[16.3.1.0^{2,6}.0^{10,15}]docosa-1(22),2,5,10(15),11,13,18,20-octaene-3-carbonitrile |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=C1C=C(F)C=C2 |
---|
InChI Identifier | InChI=1S/C21H19FN6O2/c1-11-15-7-13(22)4-5-14(15)21(29)27(2)10-16-19(17(8-23)28(3)26-16)12-6-18(30-11)20(24)25-9-12/h4-7,9,11H,10H2,1-3H3,(H2,24,25) |
---|
InChI Key | IIXWYSCJSQVBQM-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as macrolactams. These are cyclic amides of amino carboxylic acids, having a 1-azacycloalkan-2-one structure, or analogues having unsaturation or heteroatoms replacing one or more carbon atoms of the ring. They are nitrogen analogues (the a nitrogen atom replacing the o atom of the cyclic carboxylic acid group ) of the naturally occurring macrolides. |
---|
Kingdom | Organic compounds |
---|
Super Class | Phenylpropanoids and polyketides |
---|
Class | Macrolactams |
---|
Sub Class | Not Available |
---|
Direct Parent | Macrolactams |
---|
Alternative Parents | |
---|
Substituents | - Macrolactam
- 3-pyrazolylpyridine
- Alkyl aryl ether
- Aminopyridine
- Aryl fluoride
- Aryl halide
- Imidolactam
- Benzenoid
- Pyridine
- Azole
- Heteroaromatic compound
- Pyrazole
- Tertiary carboxylic acid amide
- Amino acid or derivatives
- Carboxamide group
- Lactam
- Organoheterocyclic compound
- Azacycle
- Carboxylic acid derivative
- Ether
- Oxacycle
- Carbonitrile
- Nitrile
- Organic nitrogen compound
- Organic oxygen compound
- Primary amine
- Amine
- Hydrocarbon derivative
- Cyanide
- Organic oxide
- Organohalogen compound
- Organofluoride
- Organonitrogen compound
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M+H]+ | 196.356 | 30932474 | DeepCCS | [M-H]- | 193.961 | 30932474 | DeepCCS | [M-2H]- | 227.471 | 30932474 | DeepCCS | [M+Na]+ | 202.518 | 30932474 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Lorlatinib,1TMS,isomer #1 | CC1OC2=C(N[Si](C)(C)C)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C21 | 3895.3 | Semi standard non polar | 33892256 | Lorlatinib,1TMS,isomer #1 | CC1OC2=C(N[Si](C)(C)C)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C21 | 3316.2 | Standard non polar | 33892256 | Lorlatinib,1TMS,isomer #1 | CC1OC2=C(N[Si](C)(C)C)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C21 | 5200.0 | Standard polar | 33892256 | Lorlatinib,2TMS,isomer #1 | CC1OC2=C(N([Si](C)(C)C)[Si](C)(C)C)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C21 | 3684.4 | Semi standard non polar | 33892256 | Lorlatinib,2TMS,isomer #1 | CC1OC2=C(N([Si](C)(C)C)[Si](C)(C)C)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C21 | 3422.4 | Standard non polar | 33892256 | Lorlatinib,2TMS,isomer #1 | CC1OC2=C(N([Si](C)(C)C)[Si](C)(C)C)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C21 | 4749.1 | Standard polar | 33892256 | Lorlatinib,1TBDMS,isomer #1 | CC1OC2=C(N[Si](C)(C)C(C)(C)C)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C21 | 4061.9 | Semi standard non polar | 33892256 | Lorlatinib,1TBDMS,isomer #1 | CC1OC2=C(N[Si](C)(C)C(C)(C)C)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C21 | 3519.2 | Standard non polar | 33892256 | Lorlatinib,1TBDMS,isomer #1 | CC1OC2=C(N[Si](C)(C)C(C)(C)C)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C21 | 5165.7 | Standard polar | 33892256 | Lorlatinib,2TBDMS,isomer #1 | CC1OC2=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C21 | 3989.1 | Semi standard non polar | 33892256 | Lorlatinib,2TBDMS,isomer #1 | CC1OC2=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C21 | 3798.7 | Standard non polar | 33892256 | Lorlatinib,2TBDMS,isomer #1 | CC1OC2=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C21 | 4744.9 | Standard polar | 33892256 |
| Show more...
---|